Kimihiko Ito

Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary

Seiji Mabuchi, Chiaki Kawase, Deborah A. Altomare et al. · Molecular Cancer Therapeutics · 2010 · 88 citations · Full text

Medicine, Gynecology, Oncology +16

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)

Junzo Hamanishi, Nobuhiro Takeshima, Noriyuki Katsumata et al. · Institutional Repositories DataBase (IRDB) · 2021 · 82 citations · Full text

Medicine, Oncology, Pharmacology +16

Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group

Kenichi Harano, Akihiro Hirakawa, Mayu Yunokawa et al. · International Journal of Clinical Oncology · 2015 · 61 citations

Medicine, Oncology, Surgery +13

A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes

Seiji Mabuchi, Fumiaki Isohashi, Takeshi Yokoi et al. · Gynecologic Oncology · 2016 · 43 citations

Medicine, Oncology, Surgery +17

Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary

Takeshi Hisamatsu, Seiji Mabuchi, Yuri Matsumoto et al. · Molecular Cancer Therapeutics · 2013 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17